¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"quinone reductase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde reductase
    ¾Ëµ¥È÷µåȯ¿øÈ¿¼Ò
  • reductase
    ȯ¿øÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase
    ȯ¿øÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase, 5-alpha-reductase inhibitor
    5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡­ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡­åäð¤ð¥)
  • NADH-cytochrome b5 reductase
    NADH-½ÃÅäÅ©·Òb5¸®´öŸ¾ÆÁ¦
  • NADH-methemoglobin reductase
    NADH-¸ÞÆ®Çì¸ð±Û·Îºó ȯ¿øÈ¿¼Ò
  • NADPH-dependent methemoglobin reductase
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó ¸®´öŸ¾ÆÁ¦
  • glutathione reductase
    ±Û·çŸƼ¿Â ¸®´ÚŸÁ¦<ȯ¿øÈ¿¼Ò>.
  • glutathione reductase
    ±Û·çŸƼ¿Â¸®´ÚŸÁ¦<--ȯ¿øÈ¿¼Ò>
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glyoxylate reductase
    ±Û¸®¿Á½Ç»êȯ¿øÈ¿¼Ò.
  • reductase
    ¸®´öŸ¾ÆÁ¦, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • reductase
    ȯ¿øÈ¿¼Ò
  • reductase test
    ȯ¿øÈ¿¼Ò½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase, 5-alpha-reductase inhibitor
    5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡­ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡­åäð¤ð¥)
  • cystine reductase
    ½Ã½ºÆ¾È¯¿øÈ¿¼Ò(¡­ü½êª ý£áÈ).
  • cytochrome b5 reductase deficiency
    ½ÃÅäÅ©·Ò b5 ȯ¿øÈ¿¼Ò °áÇÌ
  • cytochrome reductase
    ½ÃÅäÅ©·Ò ·¹´ÚŸÁ¦<ȯ¿øÈ¿¼Ò(ü½êªý£áÈ)>.
  • dihydropteridine reductase
    Dihydropteridine reductase
  • glutathione reductase
    ±Û·çŸƼ¿Â¸®´ÚŸÁ¦<--ȯ¿øÈ¿¼Ò>
  • glutathione reductase
    ±Û·çŸƼ¿Â ¸®´ÚŸÁ¦<ȯ¿øÈ¿¼Ò>.
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glyoxylate reductase
    ±Û¸®¿Á½Ç»êȯ¿øÈ¿¼Ò.
  • glyoxylic acid reductase deficency
  • reductase
    ȯ¿øÈ¿¼Ò
  • reductase
    ¸®´öŸ¾ÆÁ¦, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • reductase test
    ȯ¿øÈ¿¼Ò½ÃÇè.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrrolo quinoline quinone
    ÇÇ·Ñ·Î Äû³î¸° Äû³í
  • quinone
    "Äû³í,"
  • quinone cycle
    Äû³í ȸ·Î(üÞÖØ).
  • coenzyme Q-cytochrome c reductase complex
    º¸È¿¼Ò(ÜÍý£áÈ) Q¡¤»çÀÌÅäÅ©·Ò C ¸®´ÚÅ×À̽º (ÔÒ) complex III
  • dihydrofolate reductase
    ÀÌ(ì£)¼ö¼Ò(â©áÈ)Æú»ê(ß«) ¸®´öÅ×À̽º
  • folic acid reductase
    Æú»ê(ß«) ¸®´ÚÅ×À̽º
  • nitrate reductase
    Áú»ê(òòß«) ¸®´ÚÅ×À̽º
  • nitrite reductase
    ¾ÆÁú»ê(ä¬òòß«)¸®´ÚÅ×À̽º
  • reductase
    "¸®´ÚÅ×À̽º, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ)"
  • ribonucleotide reductase
    ¶óÀ̺¸´ºÅ¬¸®¿ÀŸÀÌµå ¸®´ÚÅ×À̽º
  • succinate-coenzyme Q reductase
    ¼÷½Å»ê(ß«)-º¸È¿¼Ò(ÜÍý£áÈ)Q ¸®´ÚÅ×À̽º
  • thioredoxin reductase
    ŸÀÌ¿À·¹µ¶½Å ¸®´öÅ×À̽º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NQO NAD(P)H:quinone oxidoreductase
DHFR DiHydroFolate Reductase
ADR activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ...
ALDR aldose reductase
ALR aldehyde reductase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NQR NAD(P)H: quinone reductase
QR Quinone reductase
HMG-CoA reductase 3-Hydroxy-3-methylglutaryl CoA reductase
HMG-CoA reductase 3-Hydroxy-3-methylglutaryl coenzyme A reductase
TPQ 2,4,5-trihydroxyphenyl)alanine quinone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acetaldehyde reductase
    ¾Æ¼¼Æ® ¾Ëµ¥ÇÏÀ̵å ȯ¿ø È¿¼Ò
  • quinone
    Ű³í
    Ű´Ñ»êÀÇ »êÈ­¹°·Î, Ȳ»öÀÇ °áÁ¤¹°.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
quinone reductase <enzyme> Enzymes that reduce quinones to phenols usually using NADH or NADPH as a source of reducant.
(18 Nov 1997)
quinone reductases <enzyme> NAD(p)h:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. (NAD(p)h dehydrogenase (quinone)) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.
Registry number: EC 1.6.99.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
sodium-translocating NADH-quinone reductase <enzyme> From vibrio alginolyticus; na+ dependent activation is located in the NADH-quinone reductase segment; reduces ubiquinone-1 to ubisemiquinones or ubiquinol; strongly inhibited by 2-n-heptyl-4-hydroxyquinoline n-oxide; do not confuse with sodium independent NADH-quinone reductase EC 1.6.99.2
Registry number: EC 1.6.5.-
Synonym: nqr-1, na-translocating NADH-quinone reductase, nqr gene product
(26 Jun 1999)
sulfide quinone reductase <enzyme> Part of the photosynthetic electron transport chain in chlorobium; reaction occurs in the dark, in the absence of oxygen
Registry number: EC 1.8.5.-
Synonym: plastoquinone reductase, sulfide-quinone oxidoreductase, sqr enzyme, sulfide-quinone reductase
(26 Jun 1999)
N-acetyldopamine-quinone isomerase <enzyme> Enzyme from insect cuticle converts n-acetyldopamine quinone to nada quinone methide
Registry number: EC 5.3.2.-
Synonym: nada-quinone isomerase
(26 Jun 1999)
NADPH dehydrogenase (quinone) A flavoprotein similar to NADH dehydrogenase (quinone), but oxidizing NADPH.
Synonym: DT-diaphorase, menadione reductase, phylloquinone reductase, quinone reductase.
(05 Mar 2000)
NAD(p)h dehydrogenase (quinone) <enzyme> A flavoprotein that reversibly catalyses the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. Since the enzyme is a part of the mitochondrial respiratory chain, defects or deficiencies of this enzyme are an important cause of neurological diseases such as parkinsonism. It may have a protective effect against cancer caused by quinones or their metabolic precursors. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine.
Chemical name: NAD(P)H:(quinone-acceptor) oxidoreductase
Registry number: EC 1.6.99.2
(12 Dec 1998)
dopa quinone An oxidation product of dopa and an intermediate in the formation of melanin from tyrosine.
(05 Mar 2000)
quinone Aromatic dicarbonyl compound derived from a dihydroxy aromatic compound. Ubiquinone (coenzyme Q) is a dimethoxy dicarbonyl derivative of benzene involved in electron transport. Other quinones may act as tanning agents.
(18 Nov 1997)
quinone methide isomerase <enzyme> From insect cuticle; converts 4-alkyl catechols to quinone methides
Registry number: EC 5.3.2.-
Synonym: o-quinone-quinone methide isomerase, 4-alkyl-o-quinone-2-hydroxy-4-quinone methide isomerase
(26 Jun 1999)
quinone methide tautomerase <enzyme> Enzyme from insect cuticle converts n-acetyldopamine quionone methide to 1,2-dehydro-n-acetyldopamine
Registry number: EC 5.3.2.-
Synonym: nada quione methide tautomerase
(26 Jun 1999)
acetoacetyl-CoA reductase An oxidoreductase catalyzing interconversion of a 3-oxoacyl-CoA and NADPH, and the corresponding d-3-hydroxyacyl-CoA, and NADP+. A step in fatty acid synthesis.
(05 Mar 2000)
acetohexamide reductase <enzyme> Catalyses the conversion of acetohexamide to (-)-hydroxyhexamide
Registry number: EC 1.1.1.-
(26 Jun 1999)
acryloyl-CoA reductase <enzyme> Clostridium kluyveri enzyme; contains fmn, ferredoxin, and flavodoxin; can act as electron donors
Registry number: EC 1.3.99.-
Synonym: acryloyo-coenzyme a reductase
(26 Jun 1999)
aflatoxin B1 aldehyde reductase <enzyme> Catalyses the conversion of the dialdehydic form of aflatoxin b1-dihydrodiol to the dialcohol form
Registry number: EC 1.1.1.-
Synonym: aflatoxin b1-aldehyde reductase, afb1-ar
(26 Jun 1999)
aflatoxin B1 reductase <enzyme> Reduces the cyclopentenone ring of aflatoxin b1 to aflatoxicol; requires NADPH as cofactor
Registry number: EC 1.1.1.-
(26 Jun 1999)
aflatoxin G2a reductase <enzyme> Has broad substrate specificity in cell-free extracts from aspergillus parasiticus; versicolorin a hemiacetal is reduced to versicolorin c; 17-hydroxy-16,17-dihydrosterigmatocystin is reduced to a 14,17-hydrated derivative; aflatoxin g2a is converted to a 13,16-hydrated derivative of afg2
Registry number: EC 1.1.1.-
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Quinone Reductases - »õâ NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.
    Synonyms : Menaquinone Reductases, Reductases, Menaquinone, Reductases, Quinone
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quinone
    Äû³í(¹°°¨ÀÇ ¿ø·á µîÀ¸·Î ÀÌ¿ë)
  • reductase
    ȯ¿øÈ¿¼Ò
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á